Glory Health Industry Limited (Glory Health) reported a directorate change effective 2 June 2026. Executive directors Mr. Yang Huabin and Mr. Feng Yang have resigned owing to other work arrangements, with both confirming no disagreement with the board or issues requiring shareholder attention.

Mr. Yuan Haibin, aged 51, steps up from his current role as executive vice-president to join the board. Having joined the Group in June 2024, Mr. Yuan brings more than 25 years of engineering and project-management experience across China’s real-estate sector. His three-year service contract, commencing 2 June 2026, provides an annual director’s emolument of RMB0.90 million, with additional bonuses and benefits at the board’s discretion. He will stand for re-election at the next annual general meeting and thereafter be subject to retirement by rotation.

Ms. Zhang Xiaoqian, aged 36, currently vice-president overseeing human-resources management, has also been appointed executive director on a three-year term starting 2 June 2026. Her remuneration is set at RMB0.24 million per annum, alongside discretionary bonuses and benefits. A University of Canberra graduate, Ms. Zhang joined the Group in 2014 and is the daughter of Chairman Mr. Zhang Zhangsun and step-daughter of Executive Director Ms. Ruan Wenjuan. She, too, will hold office until the next annual general meeting and be subject to the customary rotation schedule.

Following these changes, the board comprises five executive directors—Mr. Zhang Zhangsun, Ms. Ruan Wenjuan, Mr. Yuan Haibin, Mr. Zhao Yuhong and Ms. Zhang Xiaoqian—alongside three independent non-executive directors. The board expressed appreciation to the departing directors for their service and welcomed the incoming appointees.